Treatment of mild to moderate heart and spleen deficiency depression using Jianpi Jieyu Decoction: a multi-center randomized controlled study

Not Applicable

Completed

• Conditions: depression; insuffispleenciency of heart and spleen

• Registration Number: ITMCTR2100004692
• Lead Sponsor: Xiyuan Hospital, Chinese Academy of Chinese

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the above-mentioned Western medical diagnosis and TCM syndrome differentiation standards;
2. Age 18-65 years old, no gender limit;
3. The HAMD-17 score is >= 17 points, <= 24 points, and the item of depression is >= 2 points;
4. Sign informed consent.

Exclusion Criteria

1. Suicidal tendency, suicide item in HAMD >= 2 points;
2. With severe anxiety symptoms, HAMA >= 21 points;
3. Patients with serious or unstable heart, liver, kidney, endocrine, blood and other medical diseases;
4. Depressive episodes secondary to other mental or physical diseases;
5. Depressive episodes of bipolar disorder;
6. Those who have taken paroxetine or other antidepressants within 5 weeks;
7. Those who are unsupervised or unable to take medication as prescribed by a doctor;
8. People with allergies;
9. Women who are pregnant or breastfeeding.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HAMD-17;

Secondary Outcome Measures

Name	Time	Method
CGI;Evaluation table of TCM symptoms;HAMA;